The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in perforator flap breast reconstruction.
The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in perforator flap breast reconstruction.
复制标题
DOI:
10.1097/prs.0b013e3181f059c7
复制
发表时间:
2010-11
影响因子:
3.6
通讯作者:
Frangioni JV
中科院分区:
文献类型:
--
作者:
Lee BT;Hutteman M;Gioux S;Stockdale A;Lin SJ;Ngo LH;Frangioni JV
The ability to determine flap perfusion in reconstructive surgery is still primarily based on clinical examination. In this study, we demonstrate the use of an intraoperative, near infrared (NIR) fluorescence imaging system for evaluation of perforator location and flap perfusion. Indocyanine green (ICG) was injected intravenously in six breast cancer patients undergoing a deep inferior epigastric perforator (DIEP) flap breast reconstruction after mastectomy. Three dose levels of ICG were assessed using the Fluorescence-Assisted Resection and Exploration (FLARE™) imaging system. This system uses light emitting diodes (LED) for fluorescence excitation; different from current commercially available systems. In this pilot study, the operating surgeons were blinded to the imaging results. Use of the FLARE™ system was successful in all six study subjects with no complications or sequelae. Among the three dose levels, 4 mg per injection resulted in the highest observed contrast-to-background ratio (CBR), signal-to-background ratio, and signal-to-noise ratio. However, due to small sample size, we did not have sufficient power to detect statistical significance for these pairwise comparisons at the multiple-comparison adjusted type-I error of 0.017. Six mg per injection provided a similar CBR, but also a higher residual background signal. Based on this pilot study, we conclude that NIR assessment of perforator flap breast reconstruction is feasible with an LED based system, and that a dose of 4 mg of ICG per injection yields the best observed CBR compared to a dose of 2 or 6 mg for assessment of flap perfusion.